A Randomized Phase III Trial of Checkpoint Blockade in Lung CancEr Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)
Eligible for screening study DCP 001
EA5231 is temporary Closure to Accrual, effective 01/23/26
